BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Replimune Inc.
Boehringer Ingelheim
Hôpital NOVO
Inhibrx Biosciences, Inc
Seattle Children's Hospital
TScan Therapeutics, Inc.
Centre Hospitalier Universitaire de Nīmes
Massive Bio, Inc.
St. Jude Children's Research Hospital
Jemincare
Travera Inc
Fudan University
Marengo Therapeutics, Inc.
Verrica Pharmaceuticals Inc.
Vejle Hospital